• Brompheniramine
  • Chronic Lymphocytic Leukemia (CLL) Monitoring, MRD Detection, Blood
  • HIV p24 Antigen
  • Mini Respiratory Pathogen Panel (Influenza A and B and SARS-CoV-2), Molecular
  • Beta-Glucosidase, Fibroblasts
  • Beta-2 Glycoprotein 1 Antibody, IgG
  • Leishmania (Visceral Leishmaniasis) Antibody, IgG
  • Nickel, Random, Urine
  • Anti-IgE Antibody
  • Breast and Ovarian Hereditary Cancer Panel, Sequencing and Deletion/Duplication (OvaNext®)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Cancer Antigen (CA) 27- 29
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Cancer Antigen (CA) 27- 29
Medical Test

Interpretation
Access to Cancer Antigen (CA) 27- 29 is restricted.
Loading...